Paper41340872
Astragalin: A promising herbal compound with broad anticancer potential (Review).
Fu YQ and 5 others. Oncol Lett, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Astragalin: A promising herbal compound with broad anticancer potential (Review). Papers, record 41340872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41340872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References141
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36838522 | Vaccinium Species (Ericaceae): Phytochemistry and Biological Properties of Medicinal Plants. | Molecules | 2023 | https://conductscience.org/library/papers/36838522 | PubMed |
| 2 | 39552470 | In Vitro and Vivo Experiments Revealing Astragalin Inhibited Lung Adenocarcinoma Development via LINC00582/miR-140-3P/PDPK1. | J Biochem Mol Toxicol | 2024 | https://conductscience.org/library/papers/39552470 | PubMed |
| 3 | 38548868 | Global epidemiology of epithelial ovarian cancer. | Nat Rev Clin Oncol | 2024 | https://conductscience.org/library/papers/38548868 | PubMed |
| 4 | 29466695 | Molecular mechanisms and therapeutic targets in neuroblastoma. | Pharmacol Res | 2018 | https://conductscience.org/library/papers/29466695 | PubMed |
| 5 | 27730814 | Metabolic Engineering of Escherichia coli for Astragalin Biosynthesis. | J Agric Food Chem | 2016 | https://conductscience.org/library/papers/27730814 | PubMed |
| 6 | 28199969 | Astragalin-induced cell death is caspase-dependent and enhances the susceptibility of lung cancer cells to tumor necrosis factor by inhibiting the NF-кB pathway. | Oncotarget | 2017 | https://conductscience.org/library/papers/28199969 | PubMed |
| 7 | 38364933 | Discovery and validation of COX2 as a target of flavonoids in Apocyni Veneti Folium: Implications for the treatment of liver injury. | J Ethnopharmacol | 2024 | https://conductscience.org/library/papers/38364933 | PubMed |
| 8 | 35011990 | Everolimus Reduces Cancer Incidence and Improves Patient and Graft Survival Rates after Kidney Transplantation: A Multi-Center Study. | J Clin Med | 2022 | https://conductscience.org/library/papers/35011990 | PubMed |
| 9 | 33235435 | HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/33235435 | PubMed |
| 10 | 39558390 | Menin inhibitors for the treatment of acute myeloid leukemia: challenges and opportunities ahead. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/39558390 | PubMed |
| 11 | 29156716 | Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. | Oncotarget | 2017 | https://conductscience.org/library/papers/29156716 | PubMed |
| 12 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 13 | 38909621 | Colorectal cancer. | Lancet | 2024 | https://conductscience.org/library/papers/38909621 | PubMed |
| 14 | 39108625 | Improvement of glucolipid metabolism and oxidative stress via modulating PI3K/Akt pathway in insulin resistance HepG2 cells by chickpea flavonoids. | Food Chem X | 2024 | https://conductscience.org/library/papers/39108625 | PubMed |
| 15 | 34329869 | Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics. | Oral Oncol | 2021 | https://conductscience.org/library/papers/34329869 | PubMed |
| 16 | 33653412 | Lotus leaf flavonoids induce apoptosis of human lung cancer A549 cells through the ROS/p38 MAPK pathway. | Biol Res | 2021 | https://conductscience.org/library/papers/33653412 | PubMed |
| 17 | 28654261 | Astragalin Reduces Hexokinase 2 through Increasing miR-125b to Inhibit the Proliferation of Hepatocellular Carcinoma Cells in Vitro and in Vivo. | J Agric Food Chem | 2017 | https://conductscience.org/library/papers/28654261 | PubMed |
| 18 | 28300406 | Enzymatic Synthesis of a Novel Kaempferol-3-O-β-d-glucopyranosyl-(1→4)-O-α-d-glucopyranoside Using Cyclodextrin Glucanotransferase and Its Inhibitory Effects on Aldose Reductase, Inflammation, and Oxidative Stress. | J Agric Food Chem | 2017 | https://conductscience.org/library/papers/28300406 | PubMed |
| 19 | 32894420 | Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer. | Drugs | 2020 | https://conductscience.org/library/papers/32894420 | PubMed |
| 20 | 39107723 | GLUT5-overexpression-related tumorigenic implications. | Mol Med | 2024 | https://conductscience.org/library/papers/39107723 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42305471 | The flavonoid astragalin induces apoptosis in lung adenocarcinoma and correlates with a prognostic cell cycle gene signature associated with PANoptosis. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42305471 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41340872
GET https://conductscience.org/api/papers/v1/41340872/references?page=2